Takara Bio Inc.

TSE:4974 Stock Report

Market Cap: JP¥129.8b

Takara Bio Future Growth

Future criteria checks 4/6

Takara Bio is forecast to grow earnings and revenue by 25.2% and 5.3% per annum respectively. EPS is expected to grow by 25.2% per annum. Return on equity is forecast to be 4.8% in 3 years.

Key information

25.2%

Earnings growth rate

25.2%

EPS growth rate

Biotechs earnings growth9.7%
Revenue growth rate5.3%
Future return on equity4.8%
Analyst coverage

Low

Last updated08 Nov 2024

Recent future growth updates

Recent updates

Some May Be Optimistic About Takara Bio's (TSE:4974) Earnings

Nov 20
Some May Be Optimistic About Takara Bio's (TSE:4974) Earnings

Takara Bio (TSE:4974) Is Paying Out A Dividend Of ¥17.00

Nov 11
Takara Bio (TSE:4974) Is Paying Out A Dividend Of ¥17.00

Earnings and Revenue Growth Forecasts

TSE:4974 - Analysts future estimates and past financials data (JPY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/202752,9134,9773,0166,5803
3/31/202650,0844,2542,0046,8013
3/31/202547,4553,6887,7949,1243
9/30/202444,1479093,4715,723N/A
6/30/202442,822114-6,3205,926N/A
3/31/202443,5051,480-11,0671,711N/A
12/31/202347,6701,5719,88524,118N/A
9/30/202364,6718,55816,23430,312N/A
6/30/202373,21612,42427,26533,450N/A
3/31/202378,14216,01231,15036,897N/A
12/31/202282,24620,080-2,5764,845N/A
9/30/202268,73518,378-4,3695,743N/A
6/30/202266,52917,731-5,9855,147N/A
3/31/202267,69919,849-5,4186,985N/A
12/31/202162,19618,18510,94121,366N/A
9/30/202160,24417,28210,00018,304N/A
6/30/202154,42015,1685,86016,136N/A
3/31/202146,0869,5475,25613,943N/A
12/31/202039,5566,8371,6639,629N/A
9/30/202035,5084,018-1637,183N/A
6/30/202032,8532,6321,6885,876N/A
3/31/202034,5653,8192,3566,339N/A
12/31/201934,5114,2775786,324N/A
9/30/201934,9214,012-3216,779N/A
6/30/201935,6444,2161,1086,703N/A
3/31/201935,8413,657-1945,783N/A
12/31/201835,5543,3553,6637,495N/A
9/30/201835,5563,7535,1107,238N/A
6/30/201834,8043,345N/A6,970N/A
3/31/201832,3122,335N/A3,935N/A
12/31/201731,376859N/A2,683N/A
9/30/201730,302987N/A2,146N/A
6/30/201729,4241,089N/A2,198N/A
3/31/201729,3751,352N/A3,584N/A
12/31/201629,6682,282N/A3,142N/A
9/30/201629,6711,856N/A3,931N/A
6/30/201630,2741,655N/A3,525N/A
3/31/201629,7291,334N/A3,021N/A
12/31/201529,3821,660N/A3,556N/A
9/30/201528,255704N/A3,073N/A
6/30/201526,951909N/A2,977N/A
3/31/201525,969963N/A3,558N/A
12/31/201425,031844N/A2,409N/A
9/30/201424,5991,647N/A2,424N/A
6/30/201424,5141,742N/A3,316N/A
3/31/201423,9051,470N/A2,251N/A
12/31/201322,8151,291N/A2,171N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 4974's forecast earnings growth (25.2% per year) is above the savings rate (0.3%).

Earnings vs Market: 4974's earnings (25.2% per year) are forecast to grow faster than the JP market (7.8% per year).

High Growth Earnings: 4974's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 4974's revenue (5.3% per year) is forecast to grow faster than the JP market (4.1% per year).

High Growth Revenue: 4974's revenue (5.3% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 4974's Return on Equity is forecast to be low in 3 years time (4.8%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y